comunicacio

IDIBELL supports Health Department charges investigated following a lawsuit

Leave a Comment / Sin categorizar / By

Four senior officials of the Department of Health have received a complaint from the Union of the National Police Force, Police Justice (Jupol) and the Association of the Civil Guard, Civil Justice (Jucil), due to the delay in vaccination of National Police and the Civil Guard offices destined to Catalonia. They are Carmen Cabezas, Secretary […]

IDIBELL supports Health Department charges investigated following a lawsuit Read More »

Daniel Bravo Andreu Private Foundation awards a grant to Carles Diez to continue cutting-edge research in cardiology

Leave a Comment / Cardiovascular Diseases Research Group (BIO-HEART), Cardiovascular, Respiratory and Systemic Diseases and cellular aging Program, Translational Medicine Area / By

The Daniel Bravo Andreu Private Foundation has awarded its grants for biomedical research stays at benchmark centres abroad to PhD candidate Carles Diez of Bellvitge University Hospital–Bellvitge Biomedical Research Institute (IDIBELL)

Daniel Bravo Andreu Private Foundation awards a grant to Carles Diez to continue cutting-edge research in cardiology Read More »

The solidarity campaign “Elles contra l’ELA” kicks off

Leave a Comment / Neurologic Diseases and Neurogenetics , Neuroscience Area, Neuroscience Program / By

The “Elles contra ELA” solidarity campaign begins today with the aim of raising awareness about ALS and raising funds for research. This project is promoted by the research group on neurological and neurogenetic diseases of the Bellvitge Biomedical Research Institute (IDIBELL), with the support of the Catalan Foundation of ALS Miquel Valls, the sponsorship of

The solidarity campaign “Elles contra l’ELA” kicks off Read More »

IDIBELL researchers present a new recombinant protein that reverses the proinflammatory state of cells in patients with lupus

Leave a Comment / Genes, Disease and Therapy Program, Immune-inflammatory Processes and Gene Therapeutics, Translational Medicine Area / By

The protein can slow down the proinflammatory activity of the immune cells and, therefore, stop their body attack.

IDIBELL researchers present a new recombinant protein that reverses the proinflammatory state of cells in patients with lupus Read More »

Scroll to Top